10 Search Results

q=Kidney

Search Again


Shreeram Akilesh , MD, PhD

Email: shreeram@uw.edu

Phone: (206) 598-6408

Dr. Akilesh is presently applying next generation genomic tools and analyses to understand the development, structure and function of the kidney and its component cells in health and disease.

View Bio

Shaliender Bhatia , MD

Email: sbhatia@u.washington.edu

Phone: (206) 288-6765

Dr. Bhatia’s research efforts are mostly focused on clinical trials that aim at improving outcomes in skin cancers (especially Melanoma and Merkel cell carcinoma) and Kidney cancers. He is especially interested in those novel therapeutic approaches that stimulate the immune system against cancer and those that target therapy to the tumors in order to spare unnecessary toxicity.

View Bio

Evan Hall , MD, MPhil

Email: evanh@seattlecca.org

Phone: (206) 606-2496

Dr. Hall's research focuses on how to measure and improve quality of life for patients with cancer. His other areas of interest include physician-patient communication, the health economics of cancer and the benefits of novel modes of patient and caregiver social support, such as online communities.

View Bio

Yajuan Liu , PhD

Email: yajuan@uw.edu

Dr. Liu's research lab is currently focused on the following four projects: (1)Developing DNA sequence-based characterization of breakpoints of chromosome translocations/inversions in cancer using next generation sequencing. (2) Identifying new markers for Hepatitis C-associated hepatocellular carcinoma. (3) Correlating genetic alterations detected using genomic microarray and next generation sequencing with histology and clinical outcome in melanocytic neoplasms. (4) Use of genomic microarray analysis to rule in/out oncocytoma of the kidney in needle core biopsies. Dr. Liu's main goals are to identify cancer biomarkers and novel therapeutic targets and to develop molecular diagnostics using both conventional genetics methods and new genomic approaches to aid in precision diagnostics for personalized care.

View Bio

Chris Miller , PhD

Email: cpmiller@u.washington.edu

Phone: (206) 543-3363

Dr. Miller works in Dr. Hootie Warren’s lab and is spearheading the development of a human microphysiological “tumor-on-a-chip” for accelerating investigation of the barriers to T cell immunotherapy in the solid tumor microenvironment, including the extracellular matrix and the vascular endothelium. Efforts are focused on the most common type of kidney cancer, renal cell carcinoma. Dr. Miller has experience developing the human 3D vascularized renal-cell-carcinoma-on-a-chip that faithfully recapitulates angiogenic blood vessel sprouting in the presence of patient tumor spheroids but not normal-adjacent kidney cells. The tumor-on-a-chip approach is broadly applicable to a variety of solid tumors.

View Bio

Michael Schweizer , MD

Email: schweize@uw.edu

Phone: (206) 288-6252

Dr. Schweizer cares for patients with genitourinary cancers that include prostate, testicular, kidney, and bladder.

View Bio

John Thompson , MD

Email: jat@uw.edu

Phone: (206) 288-2044

Dr. Thompson leads clinical research efforts focusing on novel therapies such as cancer immunotherapy, specially activated lymphocytes and cytokines, and the use of stem cell transplants for kidney cancer and melanoma. His overall professional goal is to develop better approaches to the diagnosis and treatment of melanoma and kidney cancer.

View Bio

Maria Tretiakova , MD, PhD

Email: mariast@uw.edu

Phone: (206) 897-4294

Dr. Tretiakova's clinical specialty is general surgical pathology with special emphasis on genitourinary pathology. Her main research interests are focused on prostate, kidney and bladder cancer biomarkers and novel therapeutic targets using tissue microarrays, immunohistochemistry, molecular pathology, and digital imaging. In addition to clinical and research activities, Dr. Tretiakova directs the Diagnostic Pathology clerkship and coordinates residents/fellows rotations at the Harborview Medical Center.

View Bio

Scott Tykodi , MD, PhD

Email: stykodi@fredhutch.org

Phone: (206) 606-7763

Dr. Tykodi treats patients with kidney cancer and melanoma. He is particularly interested in the application of immune therapies to the treatment of cancer. His research focus is in the clinical application and translational study of natural or induced T-cell immunity targeting renal cell carcinoma and other cancers.

View Bio

Cathy Yeung , PhD, PharmD

Email: cathyy@u.washington.edu

Phone: (206) 897-4709

Dr. Yeung's research includes both basic science and translational studies, and spans from the determination of molecular mechanisms of altered drug metabolism using 3-dimensional cell culture techniques to the evaluation of the effect of drugs and nutritional supplements on health outcomes in patients receiving hemodialysis. She is also involved in the development of a kidney on a chip microphysiological system that can be used in preclinical drug toxicity screening.

View Bio